Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Efficacy of omeprazole/sodium bicarbonate treatment in gastroesophageal reflux disease: a systematic review.

Higuera-de-la-Tijera F.

Medwave. 2018 Mar 14;18(2):e7179. doi: 10.5867/medwave.2018.02.7179. Review. Spanish, English.

PMID:
29547594
2.

Dialysate and serum potassium in hemodialysis.

Hung AM, Hakim RM.

Am J Kidney Dis. 2015 Jul;66(1):125-32. doi: 10.1053/j.ajkd.2015.02.322. Epub 2015 Mar 28. Review. Erratum in: Am J Kidney Dis. 2015 Nov;66(5):931. Dosage error in article text.

PMID:
25828570
3.

Challenges of correlating pH change with relief of clinical symptoms in gastro esophageal reflux disease: a phase III, randomized study of Zegerid versus Losec.

Walker D, Ng Kwet Shing R, Jones D, Gruss HJ, Reguła J.

PLoS One. 2015 Feb 23;10(2):e0116308. doi: 10.1371/journal.pone.0116308. eCollection 2015.

4.

Once-daily omeprazole/sodium bicarbonate heals severe refractory reflux esophagitis with morning or nighttime dosing.

Orbelo DM, Enders FT, Romero Y, Francis DL, Achem SR, Dabade TS, Crowell MD, Geno DM, DeJesus RS, Namasivayam V, Adamson SC, Arora AS, Majka AJ, Alexander JA, Murray JA, Lohse M, Diehl NN, Fredericksen M, Jung KW, Houston MS, O'Neil AE, Katzka DA.

Dig Dis Sci. 2015 Jan;60(1):146-62. doi: 10.1007/s10620-013-3017-y. Epub 2014 Jan 22.

PMID:
24448652
5.

Gaviscon® vs. omeprazole in symptomatic treatment of moderate gastroesophageal reflux. a direct comparative randomised trial.

Pouchain D, Bigard MA, Liard F, Childs M, Decaudin A, McVey D.

BMC Gastroenterol. 2012 Feb 23;12:18. doi: 10.1186/1471-230X-12-18.

6.

Control of intra-oesophageal pH in patients with Barrett's oesophagus on omeprazole-sodium bicarbonate therapy.

Gerson LB, Mitra S, Bleker WF, Yeung P.

Aliment Pharmacol Ther. 2012 Apr;35(7):803-9. doi: 10.1111/j.1365-2036.2012.05016.x. Epub 2012 Feb 22.

7.

[On-demand treatment of nonerosive reflux disease: omeprazole plus bicarbonate powder versus omeprazole capsules].

Soifer L, Pedrana R, Parrota M, Gadea O, Naisberg G, Caruso N.

Acta Gastroenterol Latinoam. 2010 Sep;40(3):198-205. Spanish.

PMID:
21053477
8.

Pharmacokinetics of intrarectal omeprazole in alpacas.

Marmulak T, Stanley S, Kass PH, Wiebe V, McKemie D, Pusterla N.

J Vet Pharmacol Ther. 2010 Aug;33(4):371-5. doi: 10.1111/j.1365-2885.2009.01149.x.

PMID:
20646199
9.

[Acid suppression capacity of omeprazole, sodium bicarbonate and alginic acid in an oral powder combination].

Soifer L, Peralta AD, Arenoso H, Caruso N, Naisberg G.

Acta Gastroenterol Latinoam. 2009 Dec;39(4):261-6. Spanish.

PMID:
20178255
10.

Alternative vs. conventional treatment given on-demand for gastroesophageal reflux disease: a randomised controlled trial.

Farup PG, Heibert M, Høeg V.

BMC Complement Altern Med. 2009 Feb 24;9:3. doi: 10.1186/1472-6882-9-3.

11.

Acid reflux detection and symptom-reflux association using 4-day wireless pH recording combining 48-hour periods off and on PPI therapy.

Garrean CP, Zhang Q, Gonsalves N, Hirano I.

Am J Gastroenterol. 2008 Jul;103(7):1631-7. doi: 10.1111/j.1572-0241.2008.01829.x. Epub 2008 Jun 28.

PMID:
18557714
12.

Stability of partial doses of omeprazole-sodium bicarbonate oral suspension.

Johnson CE, Cober MP, Ludwig JL.

Ann Pharmacother. 2007 Dec;41(12):1954-61. Epub 2007 Oct 23.

PMID:
17956960
13.
14.
15.

Omeprazole and lansoprazole suspensions for nasogastric administration.

McAndrews KL Jr, Eastham JH.

Am J Health Syst Pharm. 1999 Jan 1;56(1):81. No abstract available.

PMID:
10048885
16.

Eradicating Helicobacter pylori reduces hypergastrinaemia during long-term omeprazole treatment.

el-Nujumi A, Williams C, Ardill JE, Oien K, McColl KE.

Gut. 1998 Feb;42(2):159-65.

17.

Pharmacokinetic evaluation of omeprazole suspension following oral administration in rats: effect of neutralization of gastric acid.

Watanabe K, Matsuka N, Furuno K, Eto K, Kawasaki H, Gomita Y.

Acta Med Okayama. 1996 Aug;50(4):219-22.

PMID:
8874584
18.

Treatment of Helicobacter pylori infection with omeprazole-amoxicillin combination therapy versus ranitidine/sodium bicarbonate-amoxicillin.

al-Assi MT, Cole RA, Karttunen TJ, el-Zimaity H, Genta RM, Graham DY.

Am J Gastroenterol. 1995 Sep;90(9):1411-4.

PMID:
7661159
19.

Epidermal growth factor is digested to smaller, less active forms in acidic gastric juice.

Playford RJ, Marchbank T, Calnan DP, Calam J, Royston P, Batten JJ, Hansen HF.

Gastroenterology. 1995 Jan;108(1):92-101.

PMID:
7806067

Supplemental Content

Loading ...
Support Center